Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 24

Related Articles by Review for PubMed (Select 19326340)

1.

Inhibitory effect of astraxanthin combined with Flavangenol on oxidative stress biomarkers in streptozotocin-induced diabetic rats.

Nakano M, Orimo N, Katagiri N, Tsubata M, Takahashi J, Van Chuyen N.

Int J Vitam Nutr Res. 2008 Jul-Sep;78(4-5):175-82. doi: 10.1024/0300-9831.78.45.175.

PMID:
19326340
2.

Pharmacology in health foods: improvement of vascular endothelial function by French maritime pine bark extract (Flavangenol).

Ohkita M, Kiso Y, Matsumura Y.

J Pharmacol Sci. 2011;115(4):461-5. Epub 2011 Mar 24. Review.

3.

Astaxanthin, oxidative stress, inflammation and cardiovascular disease.

Fassett RG, Coombes JS.

Future Cardiol. 2009 Jul;5(4):333-42. doi: 10.2217/fca.09.19. Review.

PMID:
19656058
4.

Astaxanthin: a novel potential treatment for oxidative stress and inflammation in cardiovascular disease.

Pashkow FJ, Watumull DG, Campbell CL.

Am J Cardiol. 2008 May 22;101(10A):58D-68D. doi: 10.1016/j.amjcard.2008.02.010. Review.

PMID:
18474276
5.

Role of oxidative stress in the development of diabetic nephropathy.

Ha H, Kim KH.

Kidney Int Suppl. 1995 Sep;51:S18-21. Review. No abstract available.

PMID:
7474682
6.

[Oxidative stress profile: OSP].

Ochi H, Sakai K.

Rinsho Byori. 2003 Feb;51(2):115-25. Review. Japanese.

PMID:
12690628
7.

The clinical effectiveness of chokeberry: a systematic review.

Chrubasik C, Li G, Chrubasik S.

Phytother Res. 2010 Aug;24(8):1107-14. doi: 10.1002/ptr.3226. Review.

PMID:
20572194
8.
9.
10.

Diabetes, metallothionein, and zinc interactions: a review.

Islam MS, Loots du T.

Biofactors. 2007;29(4):203-12. Review.

PMID:
18057551
11.

[Space flight and peroxidative damage].

Yang TB, Zhong P, Qu LN, Yuan YH.

Space Med Med Eng (Beijing). 2003 Dec;16(6):455-8. Review. Chinese.

PMID:
15008196
12.

Healthy properties of proanthocyanidins.

de la Iglesia R, Milagro FI, Campión J, Boqué N, Martínez JA.

Biofactors. 2010 May-Jun;36(3):159-68. doi: 10.1002/biof.79. Review.

PMID:
20232344
13.

Astaxanthin: a potential therapeutic agent in cardiovascular disease.

Fassett RG, Coombes JS.

Mar Drugs. 2011 Mar 21;9(3):447-65. doi: 10.3390/md9030447. Review.

14.

Antioxidant phytochemicals against type 2 diabetes.

Dembinska-Kiec A, Mykkänen O, Kiec-Wilk B, Mykkänen H.

Br J Nutr. 2008 May;99 E Suppl 1:ES109-17. doi: 10.1017/S000711450896579X. Review.

PMID:
18503731
15.

[Exploration on the relationship between diabetic peripheral neuropathy and oxidative stress QU ling and].

Qu L, Liang XC.

Zhongguo Zhong Xi Yi Jie He Za Zhi. 2007 Aug;27(8):764-8. Review. Chinese.

PMID:
17879547
16.

Astaxanthin in cardiovascular health and disease.

Fassett RG, Coombes JS.

Molecules. 2012 Feb 20;17(2):2030-48. doi: 10.3390/molecules17022030. Review.

17.

[Diabetes mellitus and oxidative stress].

Delattre J, Bonnefont-Rousselot D, Bordas-Fonfrèdre M, Jaudon M.

Ann Biol Clin (Paris). 1999 Jul-Aug;57(4):437-44. Review. French. No abstract available.

PMID:
10432366
18.

Cellular effects of common antioxidants.

Mandelker L.

Vet Clin North Am Small Anim Pract. 2008 Jan;38(1):199-211, vii. doi: 10.1016/j.cvsm.2007.11.002. Review.

PMID:
18249251
19.

Antioxidants and the eye.

Richer S.

Int Ophthalmol Clin. 2000 Fall;40(4):1-16. Review. No abstract available.

PMID:
11064854
20.

The importance of nutrition in the prevention of ocular disease with special reference to cataract.

Agte V, Tarwadi K.

Ophthalmic Res. 2010;44(3):166-72. doi: 10.1159/000316477. Epub 2010 Sep 9. Review.

PMID:
20829640
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk